Showing results (51-60 of 61) with videos related to
Sort By:
Pageof 7
Cancer Biotherapy & Radiopharmaceuticals|June 30, 2007
Flt3 ligand delivered in a pluronic formulation prolongs the survival of mice with orthotopic pancreatic adenocarcinomaAbdelkader E Ashour, Hēth R Turnquist, Nicole Burns, et al.The Journal of Biological Chemistry|December 31, 2002
The amyloid precursor-like protein 2 and the adenoviral E3/19K protein both bind to a conformational site on H-2Kd and regulate H-2Kd expressionChantey R Morris, Jason L Petersen, Shanna E Vargas, et al.Journal of STEM Outreach|July 11, 2022
Tailoring Our Approach in Response to the SARS-CoV-2 Pandemic and Transcending Science Outreach Modalities for Native American Students in a Cancer Research Education ProgramAislinn C Rookwood, Liliana P Bronner, Mariah A Abney, et al.Cancer Letters|December 16, 2017
Emerging trends in the immunotherapy of pancreatic cancerKasturi Banerjee, Sushil Kumar, Kathleen A Ross, et al.Plos One|September 20, 2022
The histone deacetylase inhibitor M344 as a multifaceted therapy for pancreatic cancerShelby M Knoche, Gabrielle L Brumfield, Benjamin T Goetz, et al.Methods in Enzymology|February 29, 2016
Production of Recombinant Chemokines and Validation of RefoldingChristopher T Veldkamp, Chad A Koplinski, Davin R Jensen, et al.Cancers|April 3, 2021
Amyloid Precursor-like Protein 2 Expression Increases during Pancreatic Cancer Development and Shortens the Survival of a Spontaneous Mouse Model of Pancreatic CancerBrittany J Poelaert, Shelby M Knoche, Alaina C Larson, et al.Theranostics|February 14, 2022
Nanocarriers for pancreatic cancer imaging, treatments, and immunotherapiesLuman Liu, Prakash G Kshirsagar, Shailendra K Gautam, et al.Acta Biomaterialia|April 19, 2026
A nanovaccine induces durable and functional MUC4-targeted T cell responses against pancreatic cancerLuman Liu, John Christiansen, Mansi Gulati, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|July 26, 2020
Nanoformulation of CCL21 greatly increases its effectiveness as an immunotherapy for neuroblastomaBrittany J Poelaert, Svetlana Romanova, Shelby M Knoche, et al.Pageof 7